I’d only agree that biotech is still digging out of a hole. But the specific action for BLUE is complicated with cash concerns. I am not terribly surprised at all the stock didn’t repeat the leg up today like it did first time around last month. Can you imagine how many johnny come late retailers were hoping/expecting a repeat bounce? Sell the news is not unheard of. And again recent comparisons on this board with NTLA trading down after good news as well and comparing with SGMO even over the last year or so is so flawed as well. So what SGMO has outperformed NTLA the last year; -44% to -58% respectively. 2 year performance comparison is -51% to 180% respectively. NTLA and SGMO are in completely different categories. NTLA is rolling down the highway and catching headwinds. While SGMO is unable to get out of the garage.